2015
DOI: 10.1590/0102-311x00048514
|View full text |Cite
|
Sign up to set email alerts
|

Análise dos determinantes que influenciam o tempo para o início do tratamento de mulheres com câncer de mama no Brasil

Abstract: Análise dos determinantes que influenciam o tempo para o início do tratamento de mulheres com câncer de mama no Brasil Determinants of the time between breast cancer diagnosis and initiation of treatment in Brazilian women Análisis de los determinantes que influyen en el tiempo para el inicio del tratamiento en mujeres con cáncer de mama en Brasil

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
19
1
55

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 63 publications
(76 citation statements)
references
References 34 publications
(57 reference statements)
1
19
1
55
Order By: Relevance
“…Under this perspective, the lack of an inclusive list of antineoplastic medicines and the high cost of oncological drugs are challenges that need to be overcome in order to guarantee the integrity of care. Problems to access cancer treatment have been reported and result in delays in therapy initiation and in defined health consequences [30][31][32] . Observing the data set, it seems to be a mismatch among the available instruments for the analysis of lawsuits.…”
Section: Medicines Included In the List Of Essential Medicines Of Thementioning
confidence: 99%
“…Under this perspective, the lack of an inclusive list of antineoplastic medicines and the high cost of oncological drugs are challenges that need to be overcome in order to guarantee the integrity of care. Problems to access cancer treatment have been reported and result in delays in therapy initiation and in defined health consequences [30][31][32] . Observing the data set, it seems to be a mismatch among the available instruments for the analysis of lawsuits.…”
Section: Medicines Included In the List Of Essential Medicines Of Thementioning
confidence: 99%
“…22 Além disso, um estudo de coorte realizado em 239 hospitais do Brasil mostrou que mulheres com cor da pele diferente da branca apresentam maiores chances de atrasos no diagnóstico e tratamento do câncer de mama, sugerindo uma influência do fator étnico também no manejo do diagnóstico precoce. 23 Outro ponto de destaque nesta pesquisa foi em relação à baixa escolaridade com altas proporções de analfabetismo, ou ensino fundamental incompleto. Uma análise dos determinantes que influenciam para início de tratamento para câncer de mama no Brasil, revelou que mulheres com menos de oito anos de escolaridade apresentavam mais riscos de atraso para o tratamento da doença.…”
Section: Discussionunclassified
“…Uma análise dos determinantes que influenciam para início de tratamento para câncer de mama no Brasil, revelou que mulheres com menos de oito anos de escolaridade apresentavam mais riscos de atraso para o tratamento da doença. 23 Uma investigação recente realizado no Estado de São Paulo, avaliou a implantação de um programa municipal de oferta de mamografias bianuais sem custos durante um período de dois anos, mostrou que aproximadamente 50% da população que nunca realizou mamografia se tratava de mulheres com baixo nível de instrução.…”
Section: Discussionunclassified
“…In addition to advanced staging, other factors also directly influence prognosis, such as individual characteristics, molecular and tumoral aspects, health services use and time until diagnosis or treatment initiation (Balabram et al, 2013;Caplan, 2014;Richards et al, 1999). However, the true impact of this delay has been reported as inconsistent among studies, due to the diversity of individual patient characteristics, geographic variations and differentiated health policies (Rezende, Koch, Figueiredo, & Thuler, 2009;Unger-Saldaña, 2014;Unger-Saldaña & Infante-Castañeda, 2009;Medeiros, Bergmann, Aguiar, & Thuler, 2015). In Brazil, about 70% of all cases are diagnosed in clinical stages II and III, while the chance of advanced stage at diagnosis is significantly higher among public health services users when compared to private service users (Balabram et al, 2013;Medeiros et al, 2015).…”
mentioning
confidence: 99%
“…Due to the increasing incidence of breast cancer in Brazil, in most cases presenting advanced staging, many studies on presentation delays have been published in the country (Medeiros et al, 2015;Rezende et al, 2009;Trufelli et al, 2008). However, insufficient research is still noted concerning delays in breast cancer presentation and the factors influencing this delay (Caplan, 2014;Richards et al, 1999; Unger-Saldaña & Infante-Castañeda, 2009).…”
mentioning
confidence: 99%